Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
July 18, 2001JAMA

C-Reactive Protein, Interleukin 6, and Risk of Developing Type 2 Diabetes Mellitus

View Full Paper
Ask AI
Bookmark
Share

Authors

APAruna D. Pradhan

Discussion

Loading...

Member takes

Overview

Key Points

Key points are not available for this paper at this time.

Cite This Study

Aruna D. Pradhan (2001) studied this question.

synapsesocial.com/papers/69d5740ccb7e4bf698cf4073https://doi.org/10.1001/jama.286.3.327
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1The Triumvirate: β-Cell, Muscle, Liver: A Collusion Responsible for NIDDM1988 · 2,481 citations
  2. 2The Instructive Role of Innate Immunity in the Acquired Immune Response1996 · 1,724 citations
  3. 3Plasma Concentration of Interleukin-6 and the Risk of Future Myocardial Infarction Among Apparently Healthy Men2000 · 2,445 citations
  4. 4Variability and Classification Accuracy of Serial High-Sensitivity C-Reactive Protein Measurements in Healthy Adults2001 · 409 citations
  5. 5Body mass index, diabetes, and C-reactive protein among U.S. adults.1999 · 642 citations